Researchers Develop A Simple and Fast Way to Perform Optoretinography

Researchers have created a simple and fast way to perform optoretinography, which monitors light-induced functional activity in the retina, the network of neurons at the back of our eyes that are in charge of detecting light and triggering vision.

Researchers Develop A Simple and Fast Way to Perform Optoretinography
September 23, 2022
European Commission Approves Roche’s Vabysmo for Wet AMD and DME

According to Roche, the European Commission (EC) has approved Vabysmo (faricimab) for the treatment of diabetic macular edema (DME) and wet age-related macular degeneration (AMD).

European Commission Approves Roche’s Vabysmo for Wet AMD and DME
September 22, 2022
Trukera Medical Launches New ScoutPro Osmolarity System

Trukera Medical unveiled the first product under the new company name, the ScoutPro Osmolarity System. ScoutPro is the first and only portable osmometer in the United States.

Trukera Medical Launches New ScoutPro Osmolarity System
September 13, 2022
California Passes Historic Bill Allowing Optometric Surgery

The California Legislature recently passed AC 2236, an optometric surgery bill that, if signed into law, would expand optometrists’ scope of practice in California to include some scalpel and laser eye surgeries, as well as medication injections.

California Passes Historic Bill Allowing Optometric Surgery
September 12, 2022
Researchers Develop New Gene Therapy for Rare Ciliopathy

Researchers at the National Eye Institute (NEI) have developed a gene therapy that corrects cilia deficiencies in retinal cells affected by a particular type of Leber congenital amaurosis (LCA), a disease that causes blindness in early childhood.

Researchers Develop New Gene Therapy for Rare Ciliopathy
September 09, 2022
FDA Accepts New Drug Application for NOV03 Dry Eye Treatment

The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) filing for NOV03 (perfluorohexyloctane) for the treatment of the signs and symptoms of dry eye disease, according to a joint press release from Bausch + Lomb and Novaliq.

FDA Accepts New Drug Application for NOV03 Dry Eye Treatment
September 08, 2022
TearLab Changes Its Corporate Name to Trukera Medical; Targets Corneal Health

TearLab has announced plans to strengthen its position in corneal health under the new name Trukera Medical.

TearLab Changes Its Corporate Name to Trukera Medical; Targets Corneal Health
September 08, 2022
Early Onset Of Diabetes, Hypertension Linked To Risk Of Early Glaucoma

According to a recent study by UT Southwestern researchers, people are more likely to develop primary open-angle glaucoma, the main cause of irreversible blindness worldwide, the earlier they have type 2 diabetes or hypertension in life.

Early Onset Of Diabetes, Hypertension Linked To Risk Of Early Glaucoma
September 06, 2022
First US Patient Receives Stem Cell Therapy to Treat Dry AMD

At the National Institutes of Health, a surgical team treated advanced "dry" age-related macular degeneration (AMD), also known as geographic atrophy, by successfully implanting a patch of tissue generated from patient cells.

First US Patient Receives Stem Cell Therapy to Treat Dry AMD
September 02, 2022
ESCRS Mission Zero Pledge: Hosting a Congress That Sends Zero Waste to Landfills

European Society of Cataract and Refractive Surgery (ESCRS) has adopted a first-of-its-kind vision and commitment toward sustainability and net-zero carbon emission starting from the 40th Congress of the ESCRS from 16-20 September in Milan, Italy.

ESCRS Mission Zero Pledge: Hosting a Congress That Sends Zero Waste to Landfills
September 01, 2022
More